Clinicpathological Features of Gastric Cancer in Young Patients

Yan Wang¹, Bing Lian², Ying Dong³, Ningju Wang^1*, Wenjun Yang^3*

¹Medical Oncology Department of General Hospital, Ningxia Medical University, Yinchuan, China.
²Surgical Oncology Department of General Hospital, Ningxia Medical University, Yinchuan, China.
³Key Laboratory of Reproduction and Heredity of Ningxia Region, Ningxia Medical University, Yinchuan, China.

DOI: 10.4236/jct.2014.514137                

Abstract

The incidence of gastric cancer (GC) in young patients has showed a stable or even slightly increasing trend in recent years all over the world. Little is known about the clinicpathological features of young patients with GC in Ningxia region, located in the northwest part of China. To define the clinicpathological features of GC in young patients in this region, 117 patients with GC, who were admitted to the Department of Medical Oncology, General Hospital of Ningxia Medical University, Ningxia, China, were enrolled in a retrospective database between 2000 and 2005. The data from 55 patients aged less than 35 years old were compared with those from 62 controls aged between 36 and 70. It was found that in young group, the percentages of females, the tumors in the lower third of the stomach, tumor size larger than 4 cm, macroscopic type Borrmann III tumors, poorly differentiated histology, the 7^th T stage T3 + T4, the distribution of tumor-nodes-metastasis(TNM)stage IV, surgical exploratory laparoscopy, and anemia symptoms were significantly higher than those in the control group (P < 0.05). The 5-year survival in the young group was lower than that in the control group (21.8% vs. 48.4%, P < 0.05). It was obvious that the clinicpathological features of GC in young patients were different from those in the control group. Focusing on early diagnostic rate and choosing a suitable operative treatment should be critical to improve prognosis of young patients with GC in Ningxia region of China.

Keywords

Young People, Gastric Cancer, Clinicpathological Features

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr
[2]	Moore, M.A., Eser, S., Igisinov, N., et al. (2010) Cancer Epidemiology and Control in North-Western and Central Asia-Past, Present and Future. Asian Pacific Journal of Cancer Prevention, 11, 17-32.
[3]	Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., Zou, X., et al. (2014) Annual Report on Status of Cancer in China. Chinese Journal of Cancer Research, 26, 48-58.
[4]	Piazuelo, M.B. and Correa, P. (2013) Gastric Cáncer: Overview. Colomb Med (Cali), 44, 192-201.
[5]	Tavares, A., Gandra, A., Viveiros, F., Cidade, C. and Maciel, J. (2013) Analysis of Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young and Older Patients. Pathology & Oncology Research, 19, 111-117. http://dx.doi.org/10.1007/s12253-012-9530-z
[6]	Qiu, M.Z., Wang, Z.Q., Zhang, D.S., et al. (2011) Clinicpathological Characteristics and Prognostic Analysis of Gastric Cancer in the Young Adult in China. Tumor Biology, 32, 509-514. http://dx.doi.org/10.1007/s13277-010-0145-2
[7]	Nakamura, R., Saikawa, Y., Takahashi, T., et al. (2011) Retrospective Analysis of Prognostic Outcome of Gastric Cancer in Young Patients. International Journal of Clinical Oncology, 16, 328-334. http://dx.doi.org/10.1007/s10147-011-0185-7
[8]	Ramos-De la Medina, A., Salgado-Nesme, N., Torres-Villalobos, G. and Medina-Franco, H. (2004) Clinicopathologic Characteristics of Gastric Cancer in a Young Patient Population. Journal of Gastrointestinal Surgery, 8, 240-244. http://dx.doi.org/10.1016/j.gassur.2003.12.009
[9]	Hsieh, F.J., Wang, Y.C., Hsu, J.T., Liu, K.H. and Yeh, C.N. (2012) Clinicpathological Features and Prognostic Factors of Gastric Cancer Patients Aged 40 Years or Younger. Journal of Surgical Oncology, 105, 304-309. http://dx.doi.org/10.1002/jso.22084
[10]	Kitamura, K., Taniguchi, H., Yamaguchi, T. and Takahashi, T. (1996) Early Gastric Cancer in Young Adults. The Tohoku Journal of Experimental Medicine, 179, 93-100. http://dx.doi.org/10.1620/tjem.179.93
[11]	Kunisaki, C., Akiyama, H., Nomura, M., et al. (2006) Clinicpathological Features of Gastric Carcinoma in Younger and Middle-Aged Patients: A Comparative Study. Journal of Gastrointestinal Surgery, 10, 1023-1032. http://dx.doi.org/10.1016/j.gassur.2006.03.001
[12]	Matley, P.J., Dent, D.M., Madden, M.V. and Price, S.K. (1988) Gastric Carcinoma in Young Adults. Annals of Surgery, 208, 593-596. http://dx.doi.org/10.1097/00000658-198811000-00008
[13]	Okamoto, T., Makino, M., Kawasumi, H., et al. (1988) Comparative Study of Gastric Cancer in Young and Aged Patients. European Surgical Research, 20, 149-155. http://dx.doi.org/10.1159/000128754
[14]	Hsieh, F.J., Wang, Y.C., Hsu, J.T., Liu, K.H. and Yeh, C.N. (2012) Clinicpathological Features and Prognostic Factors of Gastric Cancer Patients Aged 40 Years or Younger. Journal of Surgical Oncology, 105, 304-309. http://dx.doi.org/10.1002/jso.22084
[15]	Santoro, R., Carboni, F., Lepiane, P., Ettorre, G.M. and Santoro, E. (2007) Clinicpathological Features and Prognosis of Gastric Cancer in Young European Adults. British Journal of Surgery, 94, 737-742. http://dx.doi.org/10.1002/bjs.5600
[16]	Kim, D.Y., Ryu, S.Y., Kim, Y.J. and Kim, S.K. (2003) Clinicpathological Characteristics of Gastric Cancer in Young Patients. Langenbeck’s Archives of Surgery 388, 245-249. http://dx.doi.org/10.1007/s00423-003-0387-1
[17]	Derakhshan, M.H., Liptrot, S., Paul, J., Brown, I.L., Morrison, D. and McColl, K.E. (2009) Oesophageal and Gastric Intestinal-Type Adenocarcinomas Show the Same Male Predominance Due to a 17 Year Delayed Development in Females. Gut, 58, 16-23. http://dx.doi.org/10.1136/gut.2008.161331
[18]	Wakui, S., Motohashi, M., Muto, T., Takahashi, H., Hano, H., Jutabha, P., et al. (2008) Sex-Associated Difference in Estrogen Receptor β Expression in N-Methyl-N’-Nitro-N-Nitrosoguanidine-Induced Gastric Cancers in Rats. Langenbeck’s Archives of Surgery, 393, 37-43.